These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 29978307)

  • 1. Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial.
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; El Shafie R; Nicolay NH; Debus J; Rief H
    Strahlenther Onkol; 2018 Oct; 194(10):911-920. PubMed ID: 29978307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life and Radiation-induced Late Toxicity Following Intensity-modulated
    Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie R; Nicolay NH; Debus J; Rief H
    Anticancer Res; 2018 Aug; 38(8):4953-4960. PubMed ID: 30061275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced toxicity after image-guided and intensity-modulated radiotherapy versus external beam radiotherapy for patients with spinal bone metastases (IRON-1): a study protocol for a randomized controlled pilot trial.
    Meyerhof E; Sprave T; Welte SE; Nicolay NH; Förster R; Bostel T; Bruckner T; Schlampp I; Debus J; Rief H
    Trials; 2017 Mar; 18(1):98. PubMed ID: 28253920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases.
    Peyraga G; Caron D; Lizee T; Metayer Y; Septans AL; Pointreau Y; Denis F; Ganem G; Lafond C; Roche S; Dupuis O
    Support Care Cancer; 2018 Jun; 26(6):1897-1903. PubMed ID: 29275524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial.
    Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
    Radiat Oncol; 2018 Oct; 13(1):212. PubMed ID: 30376859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.
    Viani GA; Viana BS; Martin JE; Rossi BT; Zuliani G; Stefano EJ
    Cancer; 2016 Jul; 122(13):2004-11. PubMed ID: 27028170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.
    Sveistrup J; af Rosenschöld PM; Deasy JO; Oh JH; Pommer T; Petersen PM; Engelholm SA
    Radiat Oncol; 2014 Feb; 9():44. PubMed ID: 24495815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical trials.
    Deng JY; Wang C; Shi XH; Jiang GL; Wang Y; Liu Y; Zhao KL
    Dis Esophagus; 2016 Nov; 29(8):1121-1127. PubMed ID: 26663710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
    Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.
    Al-Mamgani A; Van Rooij P; Tans L; Teguh DN; Levendag PC
    Technol Cancer Res Treat; 2013 Apr; 12(2):123-30. PubMed ID: 23098281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, comparative analysis of acute toxicity profile between three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in locally advanced head and neck cancer patients.
    Kucha N; Soni TP; Jakhotia N; Patni N; Singh DK; Gupta AK; Sharma LM; Goyal J
    Cancer Treat Res Commun; 2020; 25():100223. PubMed ID: 33120316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer.
    Ng SY; Colborn KL; Cambridge L; Hajj C; Yang TJ; Wu AJ; Goodman KA
    Radiother Oncol; 2016 Nov; 121(2):252-257. PubMed ID: 27751605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity modulated radiation therapy (IMRT) is not superior to three-dimensional conformal radiation (3DCRT) for adjuvant gastric radiation: A matched pair analysis.
    Chopra S; Agarwal A; Engineer R; Dora T; Thomas B; Sonawone S; Paul SN; Kannan S; Patil P; Mehta S; Shrivastava SK
    J Cancer Res Ther; 2015; 11(3):623-9. PubMed ID: 26458592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
    Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy.
    Onal C; Yuce Sari S; Yavas G; Oymak E; Birgi SD; Yigit E; Guler OC; Gultekin M; Akyurek S; Yildiz F
    Acta Oncol; 2021 Sep; 60(9):1154-1160. PubMed ID: 33999750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
    Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
    Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
    Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
    BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysis.
    Ta MH; Schernberg A; Giraud P; Monnier L; Darai É; Bendifallah S; Schlienger M; Touboul E; Orthuon A; Challand T; Huguet F; Rivin Del Campo E
    Acta Oncol; 2019 Aug; 58(8):1127-1134. PubMed ID: 31017032
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.
    Tramacere F; Arcangeli S; Pignatelli A; Castagna R; Portaluri M
    Anticancer Res; 2015 May; 35(5):3049-54. PubMed ID: 25964594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study for dosimetric assessment and clinical impact of bone marrow sparing intensity-modulated radiation therapy versus 3-dimensional conformal radiation therapy on hematological and gastrointestinal toxicities in cervical cancer.
    Kapoor AR; Bhalavat RL; Chandra M; Pareek V; Moosa Z; Markana S; Nandakumar P; Bauskar P; Shincy NV
    J Cancer Res Ther; 2022; 18(6):1490-1497. PubMed ID: 36412399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.